Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous blood versus C3F8 injection for acute corneal hydrops
RBR-109k3fmjRecruiting
- Sponsor
- Federal University of São Paulo
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in Corneal Hydrops comparing Intrastromal autologous blood injection with Intracameral C3F8 injection (2 arms). Started Jun 2023; status: recruiting.
02
Drugs
autologous bloodperflutren
03
Conditions
Corneal Hydrops
Beyond the preview
Go deeper on RBR-109k3fmj.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-109k3fmj.